Stockreport

FDA OKs subcutaneous version of J&J's Darzalex [Seeking Alpha]

Halozyme Therapeutics, Inc.  (HALO) 
Last halozyme therapeutics, inc. earnings: 2/24 04:02 pm Check Earnings Report
US:NASDAQ Investor Relations: halozyme.com/investors/default.aspx
PDF The FDAapprovesJNJ-1.9%The formulation is based on Halozyme's (HALO+0.6%J&J in-licensed exclusive global rights to the product from Genmab A/S (GMAB+2.6% [Read more]